Literature DB >> 16876286

Intermittent preventive treatment of malaria in pregnancy: evaluation of a new delivery approach and the policy implications for malaria control in Uganda.

Anthony K Mbonye1, Ib Bygbjerg, Pascal Magnussen.   

Abstract

The impact of intermittent preventive treatment (IPT) on malaria in pregnancy is well known. In countries where this policy is implemented, poor access and low compliance to this intervention has been widely reported. A study was designed to assess a new approach to deliver IPT to pregnant women through traditional birth attendants (TBAs), drug-shop vendors (DSVs), community reproductive health workers (CRHWs) and adolescent peer mobilisers (APMs); and compared this approach with IPT at health units. We evaluated this approach to assess user perceptions, its acceptability and sustainability. Results show that the new approach increased access and compliance to IPT. Mean gestational age at first dose of IPT was 21.0 weeks with the community approaches versus 23.1 weeks at health units, P>0.0001. Health units accessed a high proportion of adolescents, 28.4%, versus 25.0% at the new approaches, P<0.03; most primigravidae, 23.6%, versus 20.0% at the new approaches, P<0.04. The proportion of women who received two doses of SP was 67.5.2% with the new approaches versus 39.9% at health units, P<0.0001. The new approach was associated with a three-fold increase in use of ITNs from 8.8% at baseline to 23.4%. The factors that most influenced acceptability and use of IPT were trusted and easy accessible resource persons, their ability to make home visits especially with CRHWs and APMs; the support of spouses. Another factor was the high awareness on dangers of malaria in pregnancy and the benefits of IPT created by the resource persons. The women perceived better health using the first dose of sulphadoxine-pyremethamine (SP) and this compelled them to go for the second dose. IPT with this approach was highly acceptable with 89.1% of women at the new approaches intending to use it for the next pregnancy, while 48.0% of them had recommended it to other women. We suggest a review of the current policy on malaria prevention in pregnancy to allow provision of IPT through community structures that are feasible, practical and acceptable.

Entities:  

Mesh:

Year:  2006        PMID: 16876286     DOI: 10.1016/j.healthpol.2006.05.018

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  10 in total

1.  Determinants of use of intermittent preventive treatment of malaria in pregnancy: Jinja, Uganda.

Authors:  Laura R Sangaré; Andy Stergachis; Paula E Brentlinger; Barbra A Richardson; Sarah G Staedke; Mpungu S Kiwuwa; Noel S Weiss
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

Review 2.  Social and cultural factors affecting uptake of interventions for malaria in pregnancy in Africa: a systematic review of the qualitative research.

Authors:  Christopher Pell; Lianne Straus; Erin V W Andrew; Arantza Meñaca; Robert Pool
Journal:  PLoS One       Date:  2011-07-20       Impact factor: 3.240

3.  Global Call to Action: maximize the public health impact of intermittent preventive treatment of malaria in pregnancy in sub-Saharan Africa.

Authors:  R Matthew Chico; Stephanie Dellicour; Elaine Roman; Viviana Mangiaterra; Jane Coleman; Clara Menendez; Maud Majeres-Lugand; Jayne Webster; Jenny Hill
Journal:  Malar J       Date:  2015-05-18       Impact factor: 2.979

4.  Prevention and management of malaria during pregnancy: findings from a comparative qualitative study in Ghana, Kenya and Malawi.

Authors:  Christopher Pell; Arantza Meñaca; Nana A Afrah; Lucinda Manda-Taylor; Samuel Chatio; Florence Were; Abraham Hodgson; Mary J Hamel; Linda Kalilani; Harry Tagbor; Robert Pool
Journal:  Malar J       Date:  2013-11-20       Impact factor: 2.979

5.  The acceptability of intermittent screening and treatment versus intermittent preventive treatment during pregnancy: results from a qualitative study in Northern Ghana.

Authors:  Christopher Pell; Arantza Meñaca; Samuel Chatio; Abraham Hodgson; Harry Tagbor; Robert Pool
Journal:  Malar J       Date:  2014-11-18       Impact factor: 2.979

6.  Socio-demographic and regional disparities in utilization of intermittent preventive treatment for malaria in pregnancy - Nigeria demographic health survey 2013.

Authors:  Olukemi Titilope Olugbade; Olayinka Stephen Ilesanmi; Aishatu Bintu Gubio; Ikeoluwapo Ajayi; Patrick Mboya Nguku; Olufemi Ajumobi
Journal:  Pan Afr Med J       Date:  2019-01-25

7.  Access to and use of preventive intermittent treatment for Malaria during pregnancy: A qualitative study in the Chókwè district, Southern Mozambique.

Authors:  Paulo Arnaldo; Maria Isabel Cambe; Amílcar Magaço; Sérgio Chicumbe; Eduard Rovira-Vallbona; Anna Rosanas-Urgell; Sónia M Enosse
Journal:  PLoS One       Date:  2019-01-24       Impact factor: 3.240

Review 8.  Factors affecting the delivery, access, and use of interventions to prevent malaria in pregnancy in sub-Saharan Africa: a systematic review and meta-analysis.

Authors:  Jenny Hill; Jenna Hoyt; Anna Maria van Eijk; Lauren D'Mello-Guyett; Feiko O Ter Kuile; Rick Steketee; Helen Smith; Jayne Webster
Journal:  PLoS Med       Date:  2013-07-23       Impact factor: 11.069

9.  Perceptions of malaria in pregnancy and acceptability of preventive interventions among Mozambican pregnant women: implications for effectiveness of malaria control in pregnancy.

Authors:  Helena Boene; Raquel González; Anifa Valá; Maria Rupérez; César Velasco; Sónia Machevo; Charfudin Sacoor; Esperança Sevene; Eusébio Macete; Clara Menéndez; Khátia Munguambe
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

10.  The challenge of using intermittent preventive therapy with sulfadoxine/pyrimethamine among pregnant women in Uganda.

Authors:  Humphrey Wanzira; Henry Katamba; Allen Eva Okullo; Denis Rubahika
Journal:  Malar J       Date:  2016-08-09       Impact factor: 2.979

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.